menu
    • menu

    Company profile for Mediar Therapeutics

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Mediar is a preclinical stage biotechnology company developing therapeutics to halt, or even reverse, fibrosis. The platform and pipeline are based on an emerging class of novel targets – fibrotic mediators – that play key roles in modulating myofibroblast biology and the development of fibrosis in chronically damaged organs. Mediar’s foundational technology is based on pioneering research from Massachusetts General Ho...
    Mediar is a preclinical stage biotechnology company developing therapeutics to halt, or even reverse, fibrosis. The platform and pipeline are based on an emerging class of novel targets – fibrotic mediators – that play key roles in modulating myofibroblast biology and the development of fibrosis in chronically damaged organs. Mediar’s foundational technology is based on pioneering research from Massachusetts General Hospital and Brigham and Women's Hospital. The company was founded by Partners Innovation Fund in 2018 and is located at Lab Central, Cambridge’s premier biotechnology incubator.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Mediar TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    700 Main Street, North Cambridge, MA 02139
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.mediartx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/mediar-therapeutics/about/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Mediar Therapeutics Doses First Patient in Phase 2 WISPer Trial o
    Mediar Therapeutics Doses First Patient in Phase 2 WISPer Trial o

    05 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mediar-therapeutics-doses-first-patient-in-phase-2-wisper-trial-of-mtx-463-for-idiopathic-pulmonary-fibrosis-302473778.html

    PR NEWSWIRE
    05 Jun 2025
    Share Share
    Mediar, Lilly License Antibody for Idiopathic Pulmonary Fibrosis
    Mediar, Lilly License Antibody for Idiopathic Pulmonary Fibrosis

    10 Jan 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mediar-therapeutics-enters-into-global-licensing-agreement-with-lilly-to-advance-first-in-class-wisp1-antibody-for-the-treatment-of-idiopathic-pulmonary-fibrosis-ipf-302347905.html

    PR NEWSWIRE
    10 Jan 2025
    Share Share
    Mediar Therapeutics Initiates Second Clinical Program
    Mediar Therapeutics Initiates Second Clinical Program

    07 Aug 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mediar-therapeutics-initiates-second-clinical-program-in-portfolio-of-novel-first-in-class-antibodies-designed-to-halt-fibrosis-302215886.html

    PR NEWSWIRE
    07 Aug 2024
    Share Share
    Mediar begins patient dosing in US FDA approved phase 1 trial of MTX-463
    Mediar begins patient dosing in US FDA approved phase 1 trial of MTX-463

    07 May 2024

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=168956&sid=2

    PHARMABIZ
    07 May 2024
    Share Share
    Mediar Therapeutics Announces Clinical Candidates for Lead Fibrosis Programs
    Mediar Therapeutics Announces Clinical Candidates for Lead Fibrosis Programs

    25 Oct 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mediar-therapeutics-announces-clinical-candidates-for-lead-fibrosis-programs-strategic-collaborations-and-key-leadership-addition-301966378.html

    PR NEWSWIRE
    25 Oct 2023
    Share Share
    Mediar gets a spark from Pfizer’s Ignite program
    Mediar gets a spark from Pfizer’s Ignite program

    25 Oct 2023

    // Max Bayer FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/mediar-gets-spark-pfizers-ignite-program-lead-programs-progress

    Max Bayer FIERCE BIOTECH
    25 Oct 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search